SN · Pharma and healthcare · one day
Smith & Nephew (SN): news on Saturday 24 October 2026
News from the 24 hours to Saturday morning, 24 October 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage was almost entirely about reported talks on a Smith & Nephew tie-up with the orthopaedics arm of J&J, which ended over who would be CEO. The tone leans negative because the deal collapsed and one report says healthcare shares fell.
What drove it
- failed J&J merger talks
- CEO leadership dispute
- healthcare stocks slipped
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Mon 19 Oct | −6.3 | 2 |
| Tue 20 Oct | −0.7 | 3 |
| Wed 21 Oct | +0.3 | 4 |
| Thu 22 Oct | +3.2 | 2 |
| Fri 23 Oct | −3.7 | 7 |
| Sat 24 Oct | −5.7 | 21 |
| Sun 25 Oct | −2.0 | 3 |
| Mon 26 Oct | −1.2 | 4 |
2 stories · 21 headlines · strongest first
Pharma and healthcare on 24 OctoberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Smith & Nephew's discussions on merging with J&J's orthopaedics arm fall through −4.920 headlines today · 28 in all, since 23 October · Many outlets, citing the FT, report talks collapsed over who would be CEO. | ||
| −7.0 | Healthcare stocks slipped as deal fell apart | |
| −6.7 | $22 billion deal slips away | |
| −6.3 | Deal blocked amid CEO seat chaos | |
| −6.0 | Negotiations on a $22B deal ended over the chief executive role. | |
| −6.0 | Merger collapse over CEO dispute | |
| −5.8 | Major merger talks failed over CEO choice | |
| −5.8 | Same report of failed J&J deal talks | |
| −5.8 | Talks collapse over leadership dispute | |
| −5.7 | Merger talks hit leadership wall | |
| −5.7 | Talks collapse over CEO role | |
| −5.7 | Talks collapsed over leadership, per FT | |
| −5.7 | Reported collapse over leadership plans | |
| −5.7 | The FT reports the negotiations fell apart over the chief executive position. | |
| −5.5 | Company halts merger talks with J&J orthopaedics | |
| −5.5 | Market chatter: merger collapsed over leadership | |
| −5.5 | Market chatter: merger collapsed over leadership | |
| −5.5 | Market chatter: merger collapsed over leadership | |
| −5.3 | Deal dispute over CEO and debt | |
| −4.7 | Talks existed but collapsed, per FT | |
| −0.8 | Initial report of talks; neutral before collapse | |
| Smith & Nephew increases lobbying as Medicare changes wound care −0.81 headline today · Legis1 reports rising lobbying. | ||
| −0.8 | Lobbying rise amid Medicare changes; mostly factual | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Smith & Nephew: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.